RxDoctor Payments Data

Andres Borja Alvarez, MD

Critical Care Medicine · Weston, FLNPI 1477873230

Payments from drug & device makers

$544in general payments, 2019–2025

Across 20 payments — averaging $27.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Actelion Pharmaceuticals US, Inc.$175
  • Insmed, Inc.$122
  • Boehringer Ingelheim$98
  • United Therapeutics Corporation$56
  • Amgen$34
  • GSK$26
  • plus $34 from 2 others

What the payments were for

  • Food & beverage$42979%
  • Education$11521%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$544 in reported general payments places this provider in the 55th percentile of 618 critical care medicine providers in Florida.

See all critical care medicine providers in Florida

Medicare billing

Part B allowed, 2024
$81,915
Medicare patients
336
Services billed
777

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Orenitram ErTreprostinil Diolamine37$236,597
OpsumitMacitentan11$138,732
Trelegy ElliptaFluticasone/Umeclidin/Vilanter173$138,565
XolairOmalizumab13$46,390
Breztri AerosphereBudesonide/Glycopyr/Formoterol63$42,976
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr26$18,142
Arnuity ElliptaFluticasone Furoate50$15,463
Breo ElliptaFluticasone/Vilanterol33$15,438
Wixela InhubFluticasone Propion/Salmeterol26$2,648
Azelastine-FluticasoneAzelastine/Fluticasone13$2,154
Fluticasone Propionate116$1,533
Ventolin HfaAlbuterol Sulfate24$1,527
Levalbuterol Tartrate HfaLevalbuterol Tartrate16$1,423
Azelastine Hcl31$1,409
Albuterol Sulfate HfaAlbuterol Sulfate44$1,363

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Arnuity Ellipta, Breo Ellipta$26$187,607282 claims
Actelion Pharmaceuticals US, Inc.Opsumit$175$138,73211 claims
AstraZenecaBreztri Aerosphere$15$42,97663 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 618 critical care medicine providers in Florida.

Other critical care medicine in Weston

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →